SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63 BA Woldemeskel, CC Garliss, JN Blankson The Journal of clinical investigation 131 (10), 2021 | 189 | 2021 |
The BNT162b2 mRNA vaccine elicits robust humoral and cellular immune responses in people living with human immunodeficiency virus (HIV) BA Woldemeskel, AH Karaba, CC Garliss, EJ Beck, KH Wang, ... Clinical Infectious Diseases 74 (7), 1268-1270, 2022 | 149 | 2022 |
Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2 BA Woldemeskel, AK Kwaa, CC Garliss, O Laeyendecker, SC Ray, ... The Journal of clinical investigation 130 (12), 6631-6638, 2020 | 83 | 2020 |
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses AG Dykema, B Zhang, BA Woldemeskel, CC Garliss, LS Cheung, ... The Journal of clinical investigation 131 (10), 2021 | 75 | 2021 |
Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies BA Woldemeskel, AK Kwaa, JN Blankson EBioMedicine 62, 2020 | 45 | 2020 |
mRNA vaccine-elicited severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific T cells persist at 6 months and recognize the delta variant BA Woldemeskel, CC Garliss, JN Blankson Clinical Infectious Diseases 75 (1), e898-e901, 2022 | 28 | 2022 |
SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge BA Woldemeskel, CC Garliss, TY Aytenfisu, TS Johnston, EJ Beck, ... JCI insight 7 (10), 2022 | 21 | 2022 |
CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses BA Woldemeskel, AG Dykema, CC Garliss, S Cherfils, KN Smith, ... The Journal of clinical investigation 132 (5), 2022 | 21 | 2022 |
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection HS Park, JR Shapiro, I Sitaras, BA Woldemeskel, CC Garliss, A Dziedzic, ... JCI insight 7 (5), 2022 | 17 | 2022 |
SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection AG Dykema, B Zhang, BA Woldemeskel, CC Garliss, R Rashid, ... EBioMedicine 80, 2022 | 15 | 2022 |
Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV BA Woldemeskel, AH Karaba, CC Garliss, EJ Beck, TY Aytenfisu, ... Aids 36 (9), 1315-1317, 2022 | 10 | 2022 |
Proviral location affects cognate peptide–induced virus production and immune recognition of HIV-1–infected T cell clones F Dragoni, AK Kwaa, CC Traut, RT Veenhuis, BA Woldemeskel, ... The Journal of Clinical Investigation 133 (21), 2023 | 4 | 2023 |
Discordant antibody and T-cell responses to the severe acute respiratory syndrome coronavirus 2 Omicron variant in coronavirus disease 2019 messenger RNA vaccine recipients BA Woldemeskel, CC Garliss, TY Aytenfisu, TS Johnston, AL Cox, ... Clinical Infectious Diseases 75 (9), 1652-1654, 2022 | 4 | 2022 |
Low neutralisation of the omicron BA. 2 sublineage in boosted individuals who had breakthrough infections AH Karaba, TS Johnston, TY Aytenfisu, BA Woldemeskel, CC Garliss, ... The Lancet. Microbe 3 (9), e644, 2022 | 1 | 2022 |
Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient BA Woldemeskel, CC Garliss, TY Aytenfisu, TS Johnston, AL Cox, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022 | 1 | 2022 |
Humoral and Cellular Immune Response to a Third Dose of SARSCoV-2 Vaccine in Kidney Transplant Recipients on Belatacept J Mitchell, J Alejo, TP Chiang, JN Blankson, AH Karaba, B Woldemeskel, ... AMERICAN JOURNAL OF TRANSPLANTATION 22, 763-763, 2022 | | 2022 |
CELLULAR IMMUNE RESPONSES TO ENDEMIC CORONAVIRUSES, SARS-COV-2 AND COVID-19 mRNA VACCINATIONS BA Woldemeskel Johns Hopkins University, 2022 | | 2022 |
Coordination between Insulin Signaling and Ecdysone Signaling during Drosophila melanogaster Development B Woldemeskel | | 2014 |